Pulse Biosciences (PLSE) Non-Current Debt (2021 - 2023)

Pulse Biosciences (PLSE) recorded quarterly Non-Current Debt of $65.0 million in Q1 2023, little changed quarter-over-quarter from $65.0 million in Q4 2022.

Pulse Biosciences (PLSE) Non-Current Debt (2021 - 2023) Analysis & Trends

Pulse Biosciences' Non-Current Debt history runs 3 years deep, the most recent figure standing at $65.0 million for Q1 2023.

  • In Q1 2023, Non-Current Debt changed N/A year-over-year to $65.0 million; the TTM figure through Mar 2023 stood at $65.0 million (changed N/A YoY), while the FY2022 annual figure was $65.0 million, changed N/A from the prior year.
  • Non-Current Debt was $65.0 million for Q1 2023 at Pulse Biosciences, roughly flat from $65.0 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $65.0 million in Q3 2022 to a low of $41.0 million in Q1 2021.
  • Historically, Non-Current Debt has averaged $59.0 million across 3 years, with a median of $65.0 million in 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 14.71 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 12.50 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 202.80 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 4.58 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 1.86 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 8.62 Bn
10 Pulse Biosciences 1.68 Bn 1.68 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 65.00 Mn
Mar 31, 2023 65.00 Mn
Dec 31, 2022 65.00 Mn
Dec 31, 2022 65.00 Mn
Sep 30, 2022 65.00 Mn
Sep 30, 2022 65.00 Mn
Mar 31, 2021 41.00 Mn
Mar 31, 2021 41.00 Mn